OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 15 2025
0mins
Source: NASDAQ.COM
OptiNose Quarterly Performance: OptiNose reported a quarterly loss of $1.01 per share, exceeding the Zacks Consensus Estimate of a loss of $0.74, while revenues reached $18.51 million, surpassing expectations and showing growth from the previous year.
Future Outlook and Industry Context: The company's stock performance is expected to align with market trends, reflected in its Zacks Rank #3 (Hold), as investors await changes in earnings estimates for upcoming quarters amidst a favorable industry ranking in the Medical - Drugs sector.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
